AW
RLMD icon

Apricus Wealth’s Relmada Therapeutics RLMD Stock Holding History

Apricus Wealth’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$328K Hold
47,462
– – 0.16% 93
2026
Q1 		$330K Hold
47,462
– – 0.16% 89
2025
Q4 		$229K Hold
47,462
– – 0.12% 107
2025
Q3 		$95.4K Hold
47,462
– – 0.05% 126
2025
Q2 		$28.5K Sell
47,462
-1,500
-3% -$770 0.02% 114
2025
Q1 		$13.2K Hold
48,962
– – 0.01% 117
2024
Q4 		$25.5K Sell
48,962
-30,000
-38% -$73.2K 0.02% 101
2024
Q3 		$256K Buy
78,962
+100
+0.1% +$324 0.17% 85
2024
Q2 		$237K Hold
78,862
– – 0.17% 82
2024
Q1 		$367K Hold
78,862
– – 0.26% 75
2023
Q4 		$326K Buy
78,862
+1,500
+2% +$4.44K 0.25% 71
2023
Q3 		$240K Buy
77,362
+33
+0% +$98 0.21% 74
2023
Q2 		$220K Hold
77,329
– – 0.19% 76
2023
Q1 		$175K Hold
77,329
– – 0.16% 79
2022
Q4 		$270K Sell
77,329
-30,000
-28% -$263K 0.25% 71
2022
Q3 		$3.97M Buy
107,329
+73,995
+222% +$2.05M 3.95% 2
2022
Q2 		$633K Sell
33,334
-600
-2% -$13.1K 0.58% 46
2022
Q1 		$885K Hold
33,934
– – 0.72% 43
2021
Q4 		$765K Buy
+33,934
New +$755K 0.68% 52

Other funds holding RLMD

PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Apricus Wealth's RLMD Position: Q2 2026 in Review

Apricus Wealth held its Relmada Therapeutics (RLMD) position steady in Q2 2026 at 47,462 shares worth $328K. The position accounts for 0.16% of the portfolio, ranked #93.

Apricus Wealth first reported a position in RLMD in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.97M in Q3 2022. 7 funds tracked by Wall St. Rank hold RLMD as of Q2 2026.

  • Apricus Wealth held 47,462 shares of Relmada Therapeutics worth $328K as of Q2 2026.
  • Apricus Wealth left its Relmada Therapeutics share count unchanged in Q2 2026.
  • Relmada Therapeutics made up 0.16% of Apricus Wealth's portfolio in Q2 2026, its #93 holding.
  • Apricus Wealth first reported a position in Relmada Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Apricus Wealth's Relmada Therapeutics position peaked at $3.97M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q2 2026.

Based on Apricus Wealth's 13F filing for Q2 2026, filed 22 Jul 2026.